COMMUNIQUÉS West-GlobeNewswire

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/07/2024
DURHAM, N.C., July 05, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on July 1, 2024, the Compensation Committee of Chimerix’s Board of Directors granted inducement awards to two new employees of [...]
Inventiva provides an update on its NATiV3 clinical program evaluating lanifibranor in patients with MASH/NASH and its financial position
05/07/2024
Recruitment in NATiV3 clinical trial continues in both cohorts with over 80% of the targeted number of patients enrolled in the main cohort and 100% in the exploratory cohort of NATiV3. Analysis of the baseline [...]
Inventiva fait le point sur son programme clinique NATiV3 évaluant lanifibranor dans la MASH/NASH et sur sa situation financièr
05/07/2024
Le recrutement dans l'essai clinique de phase III NATiV3 se poursuit dans les deux cohortes avec plus de 80% du nombre ciblé de patients recrutés dans la cohorte principale et 100% dans la cohorte exploratoire de NATiV3 [...]
Sienna Announces Second Quarter 2024 Results Release Date and Conference Call
05/07/2024
MARKHAM, Ontario, July 05, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) announced that it will report its 2024 second quarter results after market close on Thursday, [...]
Virbac : Declaration of the number of shares and voting rights 06/2024
05/07/2024
DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]
Virbac : Déclaration d'actions et de droits de vote 06/2024
05/07/2024
DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]
ARCPOINT ANNOUNCES C$1.5 MILLION NON-BROKERED PRIVATE PLACEMENT
05/07/2024
Not for Dissemination in the United States or through U.S. Newswire Services Greenville, South Carolina, July 05, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) is pleased to [...]
Le KFSH&RC enregistre un taux de survie remarquable de 98 % pour 400 interventions chirurgicales cardiaques robotisées
05/07/2024
RIAYD, Arabie saoudite, 05 juill. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSH&RC) a franchi une étape importante dans son programme d’interventions chirurgicales [...]
Press release: SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
05/07/2024
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES Ghent, Belgium, 5 July 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the " Company " or " Sequana Medical "), a pioneer in the [...]
Updates from NurExone: Growth Conference Presentation and Website Relaunch
05/07/2024
TORONTO and HAIFA, Israel, July 05, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) (the “ Company ” or “ NurExone ”), a pioneering biopharmaceutical company, is pleased to [...]
Bionano Announces up to $30 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
05/07/2024
$10 million upfront with up to an additional $20 million upon the exercise in full of clinical milestone-linked Series Warrants SAN DIEGO, July 05, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today [...]
Extendicare Announces Timing of 2024 Second Quarter Results and Conference Call
05/07/2024
MARKHAM, Ontario, July 05, 2024 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the second quarter of 2024 after market [...]
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05/07/2024
DALLAS, July 05, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic [...]
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/07/2024
SAN DIEGO, July 05, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (the “Company”) (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of [...]
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social
05/07/2024
Dijon, le 5 juillet 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe et commercialisera prochainement un portefeuille de médicaments dédiés aux situations d’urgence , publie [...]
Long-time collaborators Botond Roska and José-Alain Sahel win the Wolf Prize 2024 in the field of medicine
05/07/2024
Botond Roska and José-Alain Sahel have been awarded the Wolf Prize in Medicine for their pioneering work on restoring vision to blind patients using optogenetic therapy. The Wolf Prize, considered one of the most [...]
FDA approves Roche’s Vabysmo prefilled syringe (PFS) for three leading causes of vision loss
05/07/2024
Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness Designed to simplify administration, Vabysmo PFS provides retina [...]
Medsenic, subsidiary of BioSenic SA, extends key patent to the United States
05/07/2024
PRESS RELEASE – PRIVILEGED INFORMATION The developed Medsenic’s composition-of-matter patent family does cover the therapeutic use of arsenic salts and metal ions through various routes of administration. Medsenic’s [...]
Medsenic, filiale de BioSenic SA, étend un brevet clé aux États-Unis
05/07/2024
COMMUNIQUE DE PRESSE – INFORMATION PRIVILEGIEE Une famille de brevets récents en cours de développement par Medsenic couvre l'utilisation thérapeutique de sels d'arsenic et d’ions métalliques par diverses voies d' [...]

Pages